The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll ...

The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20. Vikrant Shrotriya, managing director at Novo Nordisk India, talks about how ...

At about 150 hours, there are things I still haven't seen or encountered once, whether it's quests for certain regions, ...

In this episode of OPEN COLLAR, Major Gaurav Arya is joined by Lt. Gen. Syed Ata Hasnain (Retd.) to unpack the explosive escalation in the Middle East.Why did Mohammed bin Salman reportedly urge ...

Deflationary “race‑to‑the‑bottom” competition drives many essential generics below sustainable cost, prompting market exits and reduced investment, particularly for low‑priced sterile injectables.

Some foreign pharmaceutical plants that export generic drugs to the United States have glaring quality problems that can lead to drug shortages. There is a better way to assure the safety of ...

A list of 'toxic' manosphere phrases has been explained following the release of Louis Theroux's Netflix documentary.